Sirio Pharma (300791) — Net Asset Momentum
Sirio Pharma (300791) recorded a net asset momentum of 2.9% as of December 2024, with net assets of CN¥2.64 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Sirio Pharma (300791) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Sirio Pharma Net Asset Momentum (2016–2024)
This chart tracks Sirio Pharma's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is +2.9%, with net assets of CN¥2.64 Billion CNY as of December 2024. Read Sirio Pharma debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Sirio Pharma (2016–2024)
The table below shows the complete annual net asset history for Sirio Pharma from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Sirio Pharma.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥2.64 Billion | CN¥5.49 Billion | CN¥2.84 Billion | ▲ +2.9% |
| 2023 | CN¥2.57 Billion | CN¥5.20 Billion | CN¥2.63 Billion | ▼ -5.0% |
| 2022 | CN¥2.70 Billion | CN¥4.19 Billion | CN¥1.48 Billion | ▲ +6.2% |
| 2021 | CN¥2.54 Billion | CN¥3.82 Billion | CN¥1.28 Billion | ▲ +16.6% |
| 2020 | CN¥2.18 Billion | CN¥2.65 Billion | CN¥466.95 Million | ▲ +12.2% |
| 2019 | CN¥1.95 Billion | CN¥2.36 Billion | CN¥414.01 Million | ▲ +148.1% |
| 2018 | CN¥784.05 Million | CN¥1.54 Billion | CN¥759.53 Million | ▲ +35.1% |
| 2017 | CN¥580.20 Million | CN¥1.29 Billion | CN¥707.58 Million | ▲ +24.8% |
| 2016 | CN¥464.98 Million | CN¥1.46 Billion | CN¥997.00 Million | — |